Cardiome Pharma

About:

Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization.

Website: http://cardiome.com

Top Investors: CRG

Description:

Cardiome Pharma Corp. is a specialty biopharmaceutical company dedicated to the discovery, development and commercialization of new therapies that will improve the health of patients suffering from heart disease around the world. Cardiome has one marketed product, BRINAVESSTM (vernakalant IV), approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

Total Funding Amount:

$57M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

1986-01-01

Founders:

Alan Ezrin

Number of Employees:

51-100

Last Funding Date:

2016-06-01

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai